These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2433307

  • 1. Reversal of lymphocyte activation in vivo in the Kawasaki syndrome by intravenous gammaglobulin.
    Leung DY, Burns JC, Newburger JW, Geha RS.
    J Clin Invest; 1987 Feb; 79(2):468-72. PubMed ID: 2433307
    [Abstract] [Full Text] [Related]

  • 2. Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin.
    Furukawa S, Matsubara T, Jujoh K, Sasai K, Nakachi S, Sugawara T, Yabuta K, Kato H.
    Eur J Pediatr; 1990 Nov; 150(1):43-7. PubMed ID: 1706665
    [Abstract] [Full Text] [Related]

  • 3. High-dose intravenous gammaglobulin for Kawasaki disease.
    Furusho K, Kamiya T, Nakano H, Kiyosawa N, Shinomiya K, Hayashidera T, Tamura T, Hirose O, Manabe Y, Yokoyama T.
    Lancet; 1984 Nov 10; 2(8411):1055-8. PubMed ID: 6209513
    [Abstract] [Full Text] [Related]

  • 4. Clinical and immunologic aspects of Kawasaki disease.
    Leung DY.
    Immunodefic Rev; 1989 Nov 10; 1(3):261-71. PubMed ID: 2698643
    [Abstract] [Full Text] [Related]

  • 5. [Changes in CD69, CD25 and HLA-DR expressions in peripheral blood T cells in Kawasaki disease].
    Zhang YY, Huang XM, Kang ML, Gong FQ, Qian BQ.
    Zhonghua Er Ke Za Zhi; 2006 May 10; 44(5):329-32. PubMed ID: 16780706
    [Abstract] [Full Text] [Related]

  • 6. The immunologic effects of IVIG in Kawasaki disease.
    Leung DY.
    Int Rev Immunol; 1989 May 10; 5(2):197-202. PubMed ID: 8691053
    [Abstract] [Full Text] [Related]

  • 7. Selective high dose gamma-globulin treatment in Kawasaki disease: assessment of clinical aspects and cost effectiveness.
    Sato N, Sugimura T, Akagi T, Yamakawa R, Hashino K, Eto G, Iemura M, Ishii M, Kato H.
    Pediatr Int; 1999 Feb 10; 41(1):1-7. PubMed ID: 10200128
    [Abstract] [Full Text] [Related]

  • 8. Immunoregulatory T cell abnormalities in mucocutaneous lymph node syndrome.
    Leung DY, Chu ET, Wood N, Grady S, Meade R, Geha RS.
    J Immunol; 1983 May 10; 130(5):2002-4. PubMed ID: 6220072
    [Abstract] [Full Text] [Related]

  • 9. High-dose gammaglobulin therapy for Kawasaki disease.
    Nagashima M, Matsushima M, Matsuoka H, Ogawa A, Okumura N.
    J Pediatr; 1987 May 10; 110(5):710-2. PubMed ID: 2437278
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antigenic recognition by intravenous gamma-globulin of selected bacteria isolated from throats of patients with Kawasaki syndrome.
    Lekova ES, Joffe L, Glode MP.
    Pediatr Infect Dis J; 1990 Sep 10; 9(9):620-3. PubMed ID: 1700361
    [Abstract] [Full Text] [Related]

  • 12. Overview of pharmacological treatment of Kawasaki disease.
    Onouchi Z, Kawasaki T.
    Drugs; 1999 Nov 10; 58(5):813-22. PubMed ID: 10595862
    [Abstract] [Full Text] [Related]

  • 13. The treatment of Kawasaki syndrome with intravenous gamma globulin.
    Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP.
    N Engl J Med; 1986 Aug 07; 315(6):341-7. PubMed ID: 2426590
    [Abstract] [Full Text] [Related]

  • 14. IVGG therapy in Kawasaki disease: mechanism(s) of action.
    Shulman ST.
    Clin Immunol Immunopathol; 1989 Nov 07; 53(2 Pt 2):S141-6. PubMed ID: 2477184
    [Abstract] [Full Text] [Related]

  • 15. Immunomodulation by intravenous immune globulin in Kawasaki disease.
    Leung DY.
    J Allergy Clin Immunol; 1989 Oct 07; 84(4 Pt 2):588-93; discussion 593-4. PubMed ID: 2677095
    [Abstract] [Full Text] [Related]

  • 16. T cell subpopulations defined by monoclonal antibodies after HLA-identical sibling marrow transplantation. II. Activated and functional subsets of helper-inducer and cytotoxic-suppressor subpopulations defined by two-colour fluorescence flow cytometry.
    Atkinson K.
    Bone Marrow Transplant; 1986 Dec 07; 1(2):121-32. PubMed ID: 2971408
    [Abstract] [Full Text] [Related]

  • 17. Relationship between T-cell HLA-DR expression and intravenous immunoglobulin treatment response in Kawasaki disease.
    Wakiguchi H, Hasegawa S, Suzuki Y, Kudo K, Ichiyama T.
    Pediatr Res; 2015 Apr 07; 77(4):536-40. PubMed ID: 25580740
    [Abstract] [Full Text] [Related]

  • 18. Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki Disease.
    Nishihara S, Ishibashi K, Iribe K, Matsuda I.
    Lancet; 1988 Oct 22; 2(8617):973. PubMed ID: 2459575
    [No Abstract] [Full Text] [Related]

  • 19. New hope for children with Kawasaki disease.
    Lux KM.
    J Pediatr Nurs; 1991 Jun 22; 6(3):159-65. PubMed ID: 1710660
    [Abstract] [Full Text] [Related]

  • 20. Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease.
    Leung DY, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS.
    Lancet; 1989 Dec 02; 2(8675):1298-302. PubMed ID: 2480498
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.